AT-06

N/A

Report date: 2026/04/10 20:01:49

Base Information

Drug NameAT-06

Drug Alias NameAT-06AT-06 (a fusion of our PAR-peptide with human chimeric antigen receptor-macrophages (CAR-M))

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionAnti-Delta-like protein 3Anti-Seizure protein 6 homolog

TargetsDelta-like protein 3Seizure protein 6 homolog

Therapy Area/IndicationsAmyloidosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAttralus Inc

China Registration ClassN/A

Develop Information

Active CompaniesAttralus Inc

Inactive CompaniesN/A

Active IndicationsAmyloidosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A